For instance, herpes simplex virus thymidine kinase (HSV-tk) prodrug-activating gene therapy approaches have been employed in phase III clinical trial to study its therapeutic effects in glioblastoma multiforme (GBM) patients. Here, TKT is linked to glioblastoma.